Section 3.5: Pharmacy Management, Inventory, and Operations

Pharmacy Management, Inventory, and Operations

Principles of Pharmacy Inventory Control

Inventory control in institutional and community pharmacies is a critical operational balance. Maintaining excessive stock binds financial capital, increases holding (carrying) costs, and escalates the risk of drug expiration or obsolescence. Conversely, maintaining inadequate stock leads to medication stockouts, which delay therapy, compromise patient safety, and increase emergency purchasing costs. Operational success requires systematic inventory categorization, demand forecasting, and efficient procurement cycles.

Inventory Classification: ABC and VED Analyses

To prioritize management resources, pharmacies utilize classification matrices based on value and clinical criticality:

1. ABC Analysis (Expenditure-Based)

ABC analysis is based on Pareto's Principle (the 80/20 rule), classifying inventory into three categories based on the pharmacy's annual drug expenditure:

• Class A: High-value items representing approximately 70-80% of the pharmacy's annual budget, but making up only 10-20% of the physical inventory. These require strict inventory control, frequent reviews, and minimal safety stock (e.g., oncology biologics, specialized orphan drugs).
• Class B: Moderate-value items representing 15-20% of the budget and 20-30% of the inventory. These require moderate control and periodic reviews.
• Class C: Low-value items representing only 5-10% of the budget, but accounting for 50-60% of the physical inventory. These require simplified controls and larger safety stocks (e.g., generic oral analgesics, saline flushes).

2. VED Analysis (Clinical-Criticality-Based)

VED analysis classifies drugs based on the urgency of clinical need and the consequences of a stockout:

• Vital (V): Life-saving medications that are critical for patient survival. A stockout of these drugs is unacceptable as it can cause immediate harm or death (e.g., epinephrine, antivenom, code blue emergency medications).
• Essential (E): Medications used for treating serious but non-life-threatening conditions. Stockouts can cause significant patient discomfort or clinical deterioration if delayed (e.g., standard antibiotics, insulin, anti-epileptic drugs).
• Desirable (D): Medications used for mild, self-limiting conditions or elective therapies. Stockouts do not pose immediate clinical risks (e.g., multivitamins, topical moisturizers).

Crossing ABC and VED Matrices

By combining these two systems, pharmacies can prioritize their management efforts. For example:

• AV (High Value, Vital): Requires the most stringent control, daily monitoring, and direct supplier coordination.
• CV (Low Value, Vital): Large safety stocks can be maintained because carrying costs are low, but the clinical criticality is high.
• AD (High Value, Desirable): Stock levels should be kept low to avoid tying up capital on non-essential products.

Key Inventory Metrics and Calculations

The efficiency of inventory management is evaluated using key performance indicators:

• Inventory Turnover Rate (ITR): Measures how many times a pharmacy's average inventory is sold or replaced over a specified period (typically annually). $\text{ITR} = \frac{\text{Cost of Goods Sold (COGS)}}{\text{Average Inventory Value}}$
  • Low ITR: Indicates that inventory is sitting on shelves too long, tying up capital and increasing risks of theft or expiration.
  • High ITR: Indicates rapid movement, which is generally positive but, if excessively high, can signal insufficient stock levels and high risk of stockouts.
• Days of Inventory on Hand (DOH): Represents the average number of days it takes to clear current inventory. $\text{DOH} = \frac{365}{\text{ITR}}$
• Economic Order Quantity (EOQ): Balances ordering costs and holding costs to find the optimal order size: $\text{EOQ} = \sqrt{\frac{2DS}{H}}$ where $D$ is the annual demand, $S$ is the cost per order, and $H$ is the annual holding cost per unit.
• Reorder Point (ROP): The inventory level at which a new order should be placed: $\text{ROP} = (\text{Average Daily Demand} \times \text{Lead Time}) + \text{Safety Stock}$ Lead time represents the duration between placing an order and receiving the stock. Managing salvage or expired stock requires immediate segregation, reporting, and proper disposal in coordination with environmental safety standards.

Procurement & Purchasing in Saudi Arabia: The Role of NUPCO

In Saudi Arabia, public sector pharmaceutical procurement has been centralized through the National Unified Procurement Company (NUPCO). NUPCO is a government-owned entity responsible for procuring, storing, and distributing medical supplies, devices, and pharmaceuticals for all government healthcare entities (including the MOH, university hospitals, and military health services).

• Consolidated Tendering: NUPCO aggregates the demands of all public healthcare providers, utilizing massive purchasing power to negotiate lower prices from local and international manufacturers.
• Supply Chain Standardization: It standardizes the formulary items across public sectors, streamlining logistics and reducing supply chain disruptions. In alignment with Vision 2030, NUPCO also prioritizes local manufacturers to boost Saudi Arabia's domestic pharmaceutical capacity through local content requirements.

The Pharmacy and Therapeutics (P&T) Committee

The P&T Committee is an advisory body that serves as the organizational line of communication between the medical staff and pharmacy services.

• Formulary Management: The primary role of the P&T committee is to develop and maintain the hospital drug formulary. They review applications for new drug additions based on objective clinical evidence, safety data, and pharmacoeconomic evaluations.
• Therapeutic Duplication: They minimize cost and confusion by ensuring multiple drugs with identical mechanisms aren't listed unless clinically justified.
• Restrictions and Guidelines: They establish policies for "restricted drugs" (e.g., reserving certain broad-spectrum carbapenems for infectious disease approval). They also outline the emergency request process for non-formulary medications needed for individual patients.